HR 9190 · 119th Congress
To amend the Federal Food, Drug, and Cosmetic Act to authorize the use of investigational individualized medical treatments by patients diagnosed with a life-threatening disease or condition or severely debilitating illness, and for other purposes.
Latest action
Referred to the House Committee on Energy and Commerce.
Sponsor
Diana HarshbargerRepublican · TN-1Profile →Cosponsors (1)
1 R